Seattle biotechs still haven’t recovered from election season criticism of soaring drug prices, but things may improve after November elections.
Since last summer, a string of politicians — from Congress to the White House to Democratic presidential nominee Hillary Clinton — has threatened to rein in soaring drug prices. Clinton in August called on drug-maker Mylan to slash the price of its popular allergy medication.
